The Horseshoe Crab is the Unsung, and Threatened, Hero of the PandemicNews at Home
tags: natural history, COVID-19, pharmaceuticals, Marine Biology, Horseshoe Crabs
William Sargent is a consultant for the NOVA Science Series and the author of Crab Wars: A Tale of Horseshoe Crabs, Ecology, and Human Health (Brandeis University Press, September 2021).
During the mid-1800s several million horseshoe crabs were annually harvested to feed pigs and chicken and fertilize the fields around Delaware Bay. Today those same horseshoe crabs would be worth over a billion dollars and be protecting millions of people from COVID-19.
At its peak there were five companies producing what they called Cancerine fertilizer, and the eggs of the crabs were so numerous that farmers would fill their hay wagons with billions of eggs and fed them to their farm animals. But they stopped a few weeks before slaughter so their chickens and pigs wouldn’t taste like dead fish.
One would like to think that the industry was banned for conservation reasons, but it was more because of the introduction of chemical fertilizers and developers’ concerns that they couldn’t sell new bayfront homes because of the stench of millions of rotting horseshoe crabs.
But the crabs themselves seemed inexhaustible. Harvesters collected 750,000 crabs along a half-mile beach in 1855 and 1.2 million crabs along a mile long stretch of beach the following year.
But as would be expected, the population finally crashed along with the millions of shorebirds dependent on horseshoe crabs to fuel their migrations from South America to the Arctic Circle. By the late 1960s harvesters had only been able to collect 100,000 crabs a year. And birds like the endangered red knots were arriving on their Arctic nesting grounds too emaciated to start laying eggs.
The problem had not been so much that fishermen collected too many adult crabs, but that they had collected them in shallow waters before the females laid the eggs that would produce the future generations of the ancient arthropods.
Now horseshoe crabs are facing a similar crisis, but this time the stakes are significantly higher and their depletion is threatening millions of human lives.
With due regard to Anthony Fauci, horseshoe crabs are truly the unsung heroes of the pandemic.
All the syringes, vaccines and antibody kits used to fight COVID-19 have to be tested for bacterial contamination and the way that is done is with a preparation of bright blue horseshoe crab blood called Limulus lysate. A quart of the raw lysate is worth about $1500. By the same token each crab is worth about $1500 if you keep it alive and only use it for biomedical purposes.
But now the pattern of overharvesting and depletion is repeating itself. The COVID pandemic has increased the demand for horseshoe crab blood so collectors are starting to harvest the crabs when they are laying their eggs in shallow waters, the way they did during the heyday of the fertilizer industry. This will lead to a precipitous decline in future generations of crabs but the biomedical companies think it is worth the risk.
A scientist in Singapore has used gene-splicing technology to produce a recombinant form of lysate that doesn’t require killing live crabs. So far, the FDA has not approved this synthetic lysate because it didn’t want to switch horses in the middle of a pandemic. They had thirty years experience using the more sensitive and cheaper natural lysate but only two years of trials with the synthetic version, so they turned it down.
But the writing is on the wall. The lysate companies can see that the synthetic lysate will probably be approved after the pandemic quiets down and the multi-million-dollar lysate industry will come to a rapid end, along with the lucrative horseshoe crab fishery that it depends on.
Perhaps the companies can justify sacrificing a few year’s worth of horseshoe crabs because once the synthetic lysate is adopted the 450 million year old species will have another million years or so to recover. Can the same be said for humankind?